F, H., YT, C., L, C., C, F., J, Y., V, O., . . . TG, B. (2024). Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Nature communications, 15(1), 3741. https://doi.org/10.1038/s41467-024-47423-0
Chicago Style (17th ed.) CitationF, Haderk, et al. "Focal Adhesion Kinase-YAP Signaling Axis Drives Drug-tolerant Persister Cells and Residual Disease in Lung Cancer." Nature Communications 15, no. 1 (2024): 3741. https://doi.org/10.1038/s41467-024-47423-0.
MLA (9th ed.) CitationF, Haderk, et al. "Focal Adhesion Kinase-YAP Signaling Axis Drives Drug-tolerant Persister Cells and Residual Disease in Lung Cancer." Nature Communications, vol. 15, no. 1, 2024, p. 3741, https://doi.org/10.1038/s41467-024-47423-0.